Buscar
Mostrando ítems 1-2 de 2
Treatment of hypercholesterolemia with PCSK9 inhibitors in heart transplant recipients: first experience in Spain
(Sociedad Española de Cardiología, 2019-12)
Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results
(Wiley, 2015-04-23)
[Abstract] We conducted an observational study of 30 heart transplant recipients with serum low-density lipoprotein cholesterol (LDL-c) >100 mg/dl despite previous statin therapy, who were treated with rosuvastatin 10 mg ...